Helical tomotherapy for inoperable breast cancer: A new promising tool

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Chira, Ciprian ^a   Kirova, Youlia M ^a   Liem, Xavier ^a   Campana, François ^a   Peurien, Dominique ^a   Amessis, Malika ^a   Fournier Bidoz, Nathalie ^a   Pierga, Jean Yves ^a   Dendale, Rémi ^a   Bey, Pierre ^a   Fourquet, Alain ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; NAVELBINE;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BREAST ADENOCARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTINUOUS INFUSION; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INOPERABLE CANCER; LYMPHOCELE; MASTECTOMY; PREOPERATIVE RADIOTHERAPY; RADIATION DOSE; SKIN TOXICITY; SURGICAL INFECTION; TOMOTHERAPY; TREATMENT PLANNING; TREATMENT RESPONSE; BREAST NEOPLASMS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; INTENSITY MODULATED RADIATION THERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RADIATION RESPONSE; RADIOGRAPHY; TREATMENT OUTCOME; BREAST TUMOR;

ADULT; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84884822913     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/264306     Document Type: Article

References (36)

1. Singletary S. E., Allred C., Ashley P., Bassett L. W., Berry D., Bland K. I., Borgen P. I., Clark G., Edge S. B., Hayes D. F., Hughes L. L., Hutter R. V. P., Morrow M., Page D. L., Recht A., Theriault R. L., Thor A., Weaver D. L., Wieand H. S., Greene F. L., Revision of the American Joint Committee on cancer staging system for breast cancer. Journal of Clinical Oncology 2002 20 17 3628 3636 2-s2.0-0036731788 10.1200/JCO.2002.02.026 (Pubitemid 34983222)
2. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistic Branch, SEER Program Public Use tapes 1973-1998. 2000
3. El-Charnoubi W. A. G., Svendsen J. B., Tange U. B., Kroman N., Women with inoperable or locally advanced breast cancer-what characterizes them? A retrospective review of 157 cases. Acta Oncologica 2012 51 8 1081 1085
4. Kaufmann M., Hortobagyi G. N., Goldhirsch A., Scholl S., Makris A., Valagussa P., Blohmer J.-U., Eiermann W., Jackesz R., Jonat W., Lebeau A., Loibl S., Miller W., Seeber S., Semiglazov V., Smith R., Souchon R., Stearns V., Untch M., Von Minckwitz G., Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. Journal of Clinical Oncology 2006 24 12 1940 1949 2-s2.0-33646375742 10.1200/JCO.2005.02.6187 (Pubitemid 46638994)
5. The National Comprehensive Cancer Network (NCCN) Guidelines, http://www.nccn.org/professionals/physician-gls/pdf/breast.pdf
6. Bates T., Williams N. J., Bendall S., Bassett E. E., Coltart R. S., Primary chemo-radiotherapy in the treatment of locally advanced and inflammatory breast cancer. Breast 2012 21 3 330 335 2-s2.0-84857868449 10.1016/j.breast. 2012.02.002
7. Touboul E., Buffat L., Lefranc J.-P., Blondon J., Deniaud E., Mammar H., Laugier A., Schlienger M., Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer. International Journal of Radiation Oncology Biology Physics 1996 34 5 1019 1028 2-s2.0-0029865792 10.1016/0360-3016(95) 02207-4 (Pubitemid 26105439)
8. Huang E., McNeese M. D., Strom E. A., Perkins G. H., Katz A., Hortobagyi G. N., Valero V., Kuerer H. M., Singletary S. E., Hunt K. K., Buzdar A. U., Buchholz T. A., Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. International Journal of Radiation Oncology Biology Physics 2002 53 5 1225 1233 2-s2.0-0036680142 10.1016/S0360-3016(02)02878-X (Pubitemid 34787859)
9. Lerouge D., Touboul E., Lefranc J.-P., Genestie C., Moureau-Zabotto L., Blondon J., Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. International Journal of Radiation Oncology Biology Physics 2004 59 4 1062 1073 2-s2.0-3042515171 10.1016/j.ijrobp.2003.12.034 (Pubitemid 38834299)
10. Shanta V., Swaminathan R., Rama R., Radhika R., Retrospective analysis of locally advanced noninflammatory breast cancer from Chennai, South India, 1990-1999. International Journal of Radiation Oncology Biology Physics 2008 70 1 51 58 2-s2.0-37149011697 10.1016/j.ijrobp.2007.05.050 (Pubitemid 350258595)
11. Matuschek C., Bölke E., Roth S. L., Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission: results of a multivariate analysis. Strahlentherapie und Onkologie 2012 188 9 777 781
12. Cendales R., Schiappacasse L., Schnitman F., García G., Marsiglia H., Helical tomotherapy in patients with breast cancer and complex treatment volumes. Clinical and Translational Oncology 2011 13 4 268 274 2-s2.0-79960672262 10.1007/s12094-011-0652-7
13. Lawrence W., Fletcher G. H., Fletcher G. H., Levitt S. H., Criteria of operability in advanced breast cancer. Non-Disseminated Breast Cancer 1993 Berlin Germany Springer 5 9
14. Bollet M. A., Sigal-Zafrani B., Gambotti L., Extra J.-M., Meunier M., Nos C., Dendale R., Campana F., Kirova Y. M., Diéras V., Fourquet A., Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study. European Journal of Cancer 2006 42 14 2286 2295 2-s2.0-33748099517 10.1016/j.ejca.2006.03.026 (Pubitemid 44307620)
15. Fournier-Bidoz N., Kirova Y. M., Campana F., Dendale R., Fourquet A., Simplified field-in-field technique for a large-scale implementation in breast radiation treatment. Medical Dosimetry 2012 37 2 131 137 2-s2.0-84860442746 10.1016/j.meddos.2011.03.002
16. Massabeau C., Fournier-Bidoz N., Wakil G., Castro Pena P., Viard R., Zefkili S., Reyal F., Campana F., Fourquet A., Kirova Y. M., Implant breast reconstruction followed by radiotherapy: can helical tomotherapy become a standard irradiation treatment? Medical Dosimetry 2012 37 4 425 431 2-s2.0-84859885326 10.1016/j.meddos.2012.03.006
17. Castro Pena P., Kirova Y. M., Campana F., Dendale R., Bollet M. A., Fournier-Bidoz N., Fourquet A., Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. British Journal of Radiology 2009 82 979 595 599 2-s2.0-67649832012 10.1259/bjr/96865511
18. Atean I., Pointreau Y., Barillot I., Kirova Y.-M., Organs at risk and target volumes: definition for conformal radiation therapy in breast cancer. Cancer Radiothérapie 2012 16 5-6 485 492
19. Jackson A., Marks L. B., Bentzen S. M., Eisbruch A., Yorke E. D., Ten Haken R. K., Constine L. S., Deasy J. O., The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. International Journal of Radiation Oncology Biology Physics 2010 76 3, supplement S155 S160 2-s2.0-76449087147 10.1016/j.ijrobp.2009.08.074
20. Gagliardi G., Constine L. S., Moiseenko V., Correa C., Pierce L. J., Allen A. M., Marks L. B., Radiation dose-volume effects in the heart. International Journal of Radiation Oncology Biology Physics 2010 76 3, supplement S77 S85 2-s2.0-76449107176 10.1016/j.ijrobp.2009.04.093
21. Marks L. B., Bentzen S. M., Deasy J. O., Kong F.-M., Bradley J. D., Vogelius I. S., El Naqa I., Hubbs J. L., Lebesque J. V., Timmerman R. D., Martel M. K., Jackson A., Radiation dose-volume effects in the lung. International Journal of Radiation Oncology Biology Physics 2010 76 3, supplement S70 S76 2-s2.0-76449119210 10.1016/j.ijrobp.2009.06.091
22. Bollet M. A., Belin L., Reyal F., Campana F., Dendale R., Kirova Y. M., Thibault F., Diéras V., Sigal-Zafrani B., Fourquet A., Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial. Radiotherapy and Oncology 2012 102 1 82 88 2-s2.0-84455191840 10.1016/j.radonc.2011.08.017
23. Marchand V., Angelergues A., Gobaux V., Prospective and comparative evaluation of the toxicity of adjuvant concurrent chemoradiotherapy after neoadjuvant chemotherapy for breast cancer. American Journal of Clinical Oncology 2012
24. Common Terminology Criteria for Adverse Events. v4.03 (CTCAE), June 14, 2010, http://ctep.cancer.gov/protocolDevelopment/electronic-applications/ctc.htm
25. Vincent-Salomon A., Carton M., Freneaux P., Palangie T., Beuzeboc P., Mouret E., De Crémoux P., Coué O., Zafrani B., Nicolas A., Clough K., Fourquet A., Pouillart P., Sastre-Garau X., ERBB2 overexpression in breast carcinomasno positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy. European Journal of Cancer 2000 36 5 586 591 2-s2.0-17044460519 10.1016/S0959-8049(99)00339-1 (Pubitemid 30156843)
26. Vincent-Salomon A., Rousseau A., Jouve M., Beuzeboc P., Sigal-Zafrani B., Fréneaux P., Rosty C., Nos C., Campana F., Klijanienko J., Al Ghuzlan A., Sastre-Garau X., Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy. European Journal of Cancer 2004 40 10 1502 1508 2-s2.0-2942521162 10.1016/j.ejca.2004.03.014 (Pubitemid 38757737)
27. Goddu S. M., Chaudhari S., Mamalui-Hunter M., Pechenaya O. L., Pratt D., Mutic S., Zoberi I., Jeswani S., Powell S. N., Low D. A., Helical tomotherapy planning for left-sided breast cancer patients with positive lymph nodes: comparison to conventional multiport breast technique. International Journal of Radiation Oncology Biology Physics 2009 73 4 1243 1251 2-s2.0-61349186966 10.1016/j.ijrobp.2008.11.004
28. Caudrelier J.-M., Morgan S. C., Montgomery L., Lacelle M., Nyiri B., MacPherson M., Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation. Radiotherapy and Oncology 2009 90 1 99 105 2-s2.0-58149250543 10.1016/j.radonc.2008.09.028
29. Wang S., Liao Z., Wei X., Liu H. H., Tucker S. L., Hu C.-S., Mohan R., Cox J. D., Komaki R., Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). International Journal of Radiation Oncology Biology Physics 2006 66 5 1399 1407 2-s2.0-33751172931 10.1016/j.ijrobp.2006.07. 1337
30. Seidman A., Hudis C., Kathryn Pierri M., Shak S., Paton V., Ashby M., Murphy M., Stewart S. J., Keefe D., Cardiac dysfunction in the trastuzumab clinical trials experience. Journal of Clinical Oncology 2002 20 5 1215 1221 2-s2.0-0036498781 10.1200/JCO.20.5.1215 (Pubitemid 34177427)
31. Ryberg M., Nielsen D., Cortese G., Nielsen G., Skovsgaard T., Andersen P. K., New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. Journal of the National Cancer Institute 2008 100 15 1058 1067 2-s2.0-49449107089 10.1093/jnci/djn206
32. Giordano S. H., Kuo Y.-F., Freeman J. L., Buchholz T. A., Hortobagyi G. N., Goodwin J. S., Risk of cardiac death after adjuvant radiotherapy for breast cancer. Journal of the National Cancer Institute 2005 97 6 419 424 2-s2.0-14944370744 10.1093/jnci/dji067 (Pubitemid 40528604)
33. Roychoudhuri R., Robinson D., Putcha V., Cuzick J., Darby S., Møller H., Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer 2007 7, article 9 2-s2.0-33846955073 10.1186/1471-2407-7-9 (Pubitemid 46242723)
34. Coon A. B., Dickler A., Kirk M. C., Liao Y., Shah A. P., Strauss J. B., Chen S., Turian J., Griem K. L., Tomotherapy and multifield intensity-modulated radiotherapy planning reduce cardiac doses in left-sided breast cancer patients with unfavorable cardiac anatomy. International Journal of Radiation Oncology Biology Physics 2010 78 1 104 110 2-s2.0-77955877165 10.1016/j.ijrobp.2009.07. 1705
35. Fournier-Bidoz N., Kirova Y., Campana F., El Barouky J., Zefkili S., Dendale R., Bollet M., Mazal A., Fourquet A., Technique alternatives for breast radiation oncology: conventional radiation therapy to tomotherapy. Journal of Medical Physics 2009 34 3 149 152 2-s2.0-68849103954 10.4103/0971-6203.54849
36. Gonzalez V. J., Buchholz D. J., Langen K. M., Olivera G. H., Chauhan B., Meeks S. L., Ruchala K. J., Haimerl J., Lu W., Kupelian P. A., Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy. International Journal of Radiation Oncology Biology Physics 2006 65 1 284 290 2-s2.0-33645977488 10.1016/j.ijrobp.2005.12.044